Annual Current Liabilities
$102.68 M
+$18.06 M+21.34%
31 December 2023
Summary:
Cytokinetics Incorporated annual total current liabilities is currently $102.68 million, with the most recent change of +$18.06 million (+21.34%) on 31 December 2023. During the last 3 years, it has risen by +$71.48 million (+229.11%). CYTK annual current liabilities is now at all-time high.CYTK Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$109.81 M
+$7.04 M+6.84%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly total current liabilities is currently $109.81 million, with the most recent change of +$7.04 million (+6.84%) on 30 September 2024. Over the past year, it has increased by +$32.09 million (+41.29%). CYTK quarterly current liabilities is now at all-time high.CYTK Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.3% | +41.3% |
| 3 y3 years | +229.1% | +35.8% |
| 5 y5 years | +362.6% | +410.4% |
CYTK Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +229.1% | at high | +67.3% |
| 5 y | 5 years | at high | +362.6% | at high | +429.4% |
| alltime | all time | at high | +2136.0% | at high | +2652.9% |
Cytokinetics Incorporated Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $109.81 M(+6.8%) |
| June 2024 | - | $102.78 M(+15.7%) |
| Mar 2024 | - | $88.86 M(-13.5%) |
| Dec 2023 | $102.68 M(+21.3%) | $102.68 M(+32.1%) |
| Sept 2023 | - | $77.72 M(+18.4%) |
| June 2023 | - | $65.62 M(-12.8%) |
| Mar 2023 | - | $75.22 M(-11.1%) |
| Dec 2022 | $84.62 M(+17.8%) | $84.62 M(+10.6%) |
| Sept 2022 | - | $76.50 M(+14.4%) |
| June 2022 | - | $66.84 M(-0.0%) |
| Mar 2022 | - | $66.85 M(-7.0%) |
| Dec 2021 | $71.86 M(+130.3%) | $71.86 M(-11.1%) |
| Sept 2021 | - | $80.87 M(+30.9%) |
| June 2021 | - | $61.77 M(+71.9%) |
| Mar 2021 | - | $35.93 M(+15.2%) |
| Dec 2020 | $31.20 M(+19.9%) | $31.20 M(+13.2%) |
| Sept 2020 | - | $27.57 M(+21.5%) |
| June 2020 | - | $22.70 M(+9.4%) |
| Mar 2020 | - | $20.74 M(-20.3%) |
| Dec 2019 | $26.02 M(+17.3%) | $26.02 M(+20.9%) |
| Sept 2019 | - | $21.52 M(-2.0%) |
| June 2019 | - | $21.96 M(-16.4%) |
| Mar 2019 | - | $26.28 M(+18.4%) |
| Dec 2018 | $22.19 M(-31.6%) | $22.19 M(+3.3%) |
| Sept 2018 | - | $21.49 M(-21.2%) |
| June 2018 | - | $27.29 M(-29.2%) |
| Mar 2018 | - | $38.55 M(+18.8%) |
| Dec 2017 | $32.44 M(-2.4%) | $32.44 M(-23.4%) |
| Sept 2017 | - | $42.36 M(+36.4%) |
| June 2017 | - | $31.06 M(-15.6%) |
| Mar 2017 | - | $36.80 M(+10.6%) |
| Dec 2016 | $33.26 M(+5.1%) | $33.26 M(+13.4%) |
| Sept 2016 | - | $29.33 M(+11.7%) |
| June 2016 | - | $26.27 M(+6.4%) |
| Mar 2016 | - | $24.68 M(-22.0%) |
| Dec 2015 | $31.65 M(+32.7%) | $31.65 M(+5.0%) |
| Sept 2015 | - | $30.14 M(+3.5%) |
| June 2015 | - | $29.11 M(+14.7%) |
| Mar 2015 | - | $25.39 M(+6.4%) |
| Dec 2014 | $23.86 M | $23.86 M(+83.7%) |
| Sept 2014 | - | $12.99 M(-23.2%) |
| June 2014 | - | $16.92 M(-14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $19.79 M(-25.9%) |
| Dec 2013 | $26.70 M(+275.8%) | $26.70 M(-40.7%) |
| Sept 2013 | - | $45.01 M(+32.2%) |
| June 2013 | - | $34.05 M(+485.1%) |
| Mar 2013 | - | $5.82 M(-18.1%) |
| Dec 2012 | $7.11 M(+54.7%) | $7.11 M(+54.8%) |
| Sept 2012 | - | $4.59 M(+15.0%) |
| June 2012 | - | $3.99 M(-10.7%) |
| Mar 2012 | - | $4.47 M(-2.7%) |
| Dec 2011 | $4.59 M(-37.3%) | $4.59 M(-8.8%) |
| Sept 2011 | - | $5.03 M(-8.6%) |
| June 2011 | - | $5.50 M(-8.9%) |
| Mar 2011 | - | $6.04 M(-17.5%) |
| Dec 2010 | $7.32 M(-63.7%) | $7.32 M(+12.9%) |
| Sept 2010 | - | $6.49 M(-5.6%) |
| June 2010 | - | $6.88 M(-60.8%) |
| Mar 2010 | - | $17.53 M(-13.1%) |
| Dec 2009 | $20.19 M(-11.8%) | $20.19 M(-1.4%) |
| Sept 2009 | - | $20.47 M(-12.0%) |
| June 2009 | - | $23.25 M(+5.4%) |
| Mar 2009 | - | $22.06 M(-3.6%) |
| Dec 2008 | $22.88 M(-13.5%) | $22.88 M(-6.5%) |
| Sept 2008 | - | $24.47 M(-1.9%) |
| June 2008 | - | $24.95 M(-5.1%) |
| Mar 2008 | - | $26.29 M(-0.6%) |
| Dec 2007 | $26.45 M(+0.2%) | $26.45 M(+0.8%) |
| Sept 2007 | - | $26.24 M(+7.6%) |
| June 2007 | - | $24.39 M(+2.3%) |
| Mar 2007 | - | $23.85 M(-9.6%) |
| Dec 2006 | $26.39 M(+134.3%) | $26.39 M(+112.8%) |
| Sept 2006 | - | $12.40 M(+16.5%) |
| June 2006 | - | $10.65 M(+10.0%) |
| Mar 2006 | - | $9.69 M(-14.0%) |
| Dec 2005 | $11.26 M(+2.0%) | $11.26 M(+4.6%) |
| Sept 2005 | - | $10.76 M(+2.7%) |
| June 2005 | - | $10.48 M(-13.4%) |
| Mar 2005 | - | $12.10 M(+9.6%) |
| Dec 2004 | $11.04 M(+16.7%) | $11.04 M(+2.3%) |
| Sept 2004 | - | $10.79 M(+3.1%) |
| June 2004 | - | $10.47 M(+13.4%) |
| Mar 2004 | - | $9.23 M(-2.4%) |
| Dec 2003 | $9.46 M(+0.9%) | $9.46 M |
| Dec 2002 | $9.38 M | - |
FAQ
- What is Cytokinetics Incorporated annual total current liabilities?
- What is the all time high annual current liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual current liabilities year-on-year change?
- What is Cytokinetics Incorporated quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly current liabilities year-on-year change?
What is Cytokinetics Incorporated annual total current liabilities?
The current annual current liabilities of CYTK is $102.68 M
What is the all time high annual current liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual total current liabilities is $102.68 M
What is Cytokinetics Incorporated annual current liabilities year-on-year change?
Over the past year, CYTK annual total current liabilities has changed by +$18.06 M (+21.34%)
What is Cytokinetics Incorporated quarterly total current liabilities?
The current quarterly current liabilities of CYTK is $109.81 M
What is the all time high quarterly current liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly total current liabilities is $109.81 M
What is Cytokinetics Incorporated quarterly current liabilities year-on-year change?
Over the past year, CYTK quarterly total current liabilities has changed by +$32.09 M (+41.29%)